Four articles consisting of 350 cases exhibited the prognostic role of SNHG20 on cancer progression or recurrence, with a pooled HR of 2.37 (95% CI 1.60–3.51, P = 0.000, Fig. 3). This evidence concerns the gene SNHG20 and cancer.